Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q3 2021 call → NOWe need to determine if management describes that successive engagements of the same kind are coming in at progressively larger size. The question asks about deals, orders, contracts, projects, customers, sites, or programs. We need to see if management conveys that the size of what they land now is bigger than before for the same offering. Looking at the transcript, management discusses various growth areas. For example, Scott Baxter mentions new distribution wins, new programs, and expansion. But does he specifically say that the size of each new engagement is larger than previous ones? Let's examine. In the Q&A, Scott Baxter talks about new distribution wins: "we've got a couple of really big wins there to talk about 1700 doors and again we're really pleased with the initial take out and the POS work. There is another example of this year 3300 new doors, a category that's really, really important." This suggests they are getting more doors, but is that a larger size per engagement? It could be that they are expanding distribution, but it's not clear if each new program is larger than previous ones. They also mention testing with Academy and Intersport, but that's just tests. Another part: "We more than doubled our door count over 3000 stores for fall 2021 compared to spring with one of our key domestic retail partners" - that's about door count expansion, but again, that's more doors, not necessarily larger individual engagements. The question specifically asks about "successive engagements of the same kind" coming in at "progressively larger size." That means each new contract or order is bigger than the last. Management does not seem to explicitly state that. They talk about growth, new programs, and expansion, but not about the average size of each deal increasing. Also, they mention "new business development wins" and "new programs" but no comparison of size over time. The answer should be NO because there is no clear statement that the unit size of their repeatable business is escalating. They are just growing volume and expanding distribution. Thus, answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.